UMBC Biotechnology

"High stakes in cancer immunotherapy deal"

High stakes in cancer immunotherapy deal Bavarian Nordic is outlicensing its Phase 3 prostate cancer immunotherapy Prostvac to pharma heavyweight Bristol Myers Squibb for a tidy €881m.

"Biotechnology firm to bring jobs to Franklin"

Biotechnology firm to bring jobs to Franklin B2S Life Sciences is a biotechnology company that tailors medicines to specific conditions, and they have expressed interest in creating a l…

"Industrial Biotechnology presents insights on cellulose nanocrystal toxicity"

Industrial Biotechnology presents insights on cellulose nanocrystal toxicity Novel nanomaterials derived from cellulose have many promising industrial applications, are biobased and biodegradable, and can be produced at relatively low cost. Their potential toxicity--whether ingested, inhaled, on contact with the skin, or on exposure to cells within the body--is a topic of in…